Particulate matter test in small volume parenterals: critical aspects in sampling methodology

Area of Science:

• Pharmaceutical Science
• Analytical Chemistry
• Quality Control

Background:

• Particulate matter contamination is a critical quality attribute for parenteral products.
• Current U.S.P. XXI methods for small volume parenteral products (SVPs) require validation for accuracy.

Purpose of the Study:

• To critically assess the particulate matter test sampling methodology for SVPs using the light blockage method.
• To evaluate sampler reliability, particulate matter distribution, and the influence of sample preparation methods.

Main Methods:

• Tested nine liquid SVPs using three U.S.P. XXI sample preparation methods: direct analysis, unit diluted, and combined units.
• Utilized a HIAC/ROYCO model 3000 counter with a small volume sampler for particle counts.
• Assessed particulate matter distribution within ampoules for sizes >= 2 microns and >= 10 microns.

Main Results:

• The small volume aspirator sampler requires improvement and stricter validation than currently stated by U.S.P. XXI.
• Particulate matter distribution in liquid SVPs is uniform within ampoules for particles >= 2 microns and >= 10 microns.
• Different sample preparation methods yielded significantly different contamination results.

Conclusions:

• Direct analysis is the preferred method for particulate control testing of SVPs, mirroring product use conditions.
• The combining method is suitable for SVPs < 2 ml when direct analysis is not feasible.
• Enhanced validation of sampling methodology is crucial for reliable particulate matter testing.